Consultant predicts Australian recession in '09 after 17 years of grown

January 19, 2009 03:11


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


The Australian economy will slide into recession this year after an unprecedented 17 years of growth, an economic consultant said Monday. The report by the respected Australian consultant Access Economics contrasts with predictions by the International Monetary Fund in November that Australia would likely be one of the few economies in the world to grow in 2009. The Access Economics report predicted that Australia's central bank will soon slash the benchmark cash interest rate from 4.25 to 2.5 percent and that the Australian dollar will slump this year from 68 US cents to 56 cents. "For Australia, 2009 will be a year much like 1990 - the economy will be slip sliding into recession, and it won't be clear just how bad this will get," the report said.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection